NCT06167889 is a clinical trial in Aging, sponsored by Fang Tang.

Who is sponsoring NCT06167889?

NCT06167889 is sponsored by Fang Tang.

Is NCT06167889 still recruiting?

NCT06167889 is currently completed. Last updated 13 December 2023.

Last reviewed 2023-12-13 · How we verify

NCT06167889

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of Gender-specific Impact Factors on Elderly Disability and Cognitive Impairment

Completed Last updated 13 December 2023

What this trial tests

trial in Aging in 23,640 participants. Completed in 31 October 2023.

Timeline

1 January 2009

Primary endpoint
31 October 2023

31 October 2023

Quick facts

Lead sponsor	Fang Tang
Status	Completed
Study type	OBSERVATIONAL
Enrollment	23,640
Start date	1 January 2009
Primary completion	31 October 2023
Estimated completion	31 October 2023
Sites	1 location across China

Conditions studied

Aging — all drugs for Aging →

Sponsor

Fang Tang

Who can join

65 and older, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elderly disability and cognitive impairment rates were different between elderly man and woman. Sex-specific risk factors and observed gender differences across the lifespan were associated with different degrees of cognitive and activity of daily living function decline between men and women. However, some of these viewpoint remains controversial. The aim of this study is to explore the gender differences and influencing factors of disability and cognitive impairment among the elderly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Fang Tang trials

Trials by the same sponsor.

NCT07252427 — Gut Microbiota in IBD With Comorbid Depressive Disorder · recruiting
NCT06167720 — Suicide Risk Prediction in Cancer Patients · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06167889 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fang Tang
Last refreshed: 13 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing